Related Experiment Video
Updated: Jun 27, 2026
12:49
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Optimization of Liver Graft Function Using the CEPT Cocktail (Chroman-1, Emricasan, Polyamine, and Trans-ISRIB) in a
Anil Kharga1,2,3,4,5, Huyun Chen1,2,3, McLean S Taggart1,2,3
1Center for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
Organ Medicine
|June 26, 2026
Summary
The CEPT drug cocktail preserves liver function during transplantation by reducing warm ischemia injury. This treatment improves organ viability and may expand the donor liver pool for patients awaiting transplants.
Area of Science:
- Transplantation immunology
- Organ preservation
- Ischemia-reperfusion injury
Background:
- Liver transplant waiting lists exceed organ availability.
- Marginal donor livers are often discarded, limiting transplant options.
- The CEPT drug cocktail (Chroman-1, Emricasan, Polyamine, Trans-ISRIB) shows promise in preserving cell viability.
Purpose of the Study:
- To investigate the efficacy of the CEPT drug cocktail in mitigating warm ischemia-induced injury during liver transplantation.
- To assess CEPT's potential to improve hepatocellular function and graft recovery post-reperfusion.
Main Methods:
- Rat livers were subjected to room-temperature warm ischemia to simulate the anhepatic phase.
- Experimental group received CEPT supplementation during ischemia and reperfusion.
- Control group underwent ischemia without CEPT.
- Ex-vivo reperfusion was performed at 37°C for 6 hours.
Main Results:
- CEPT treatment improved hepatocellular function, evidenced by increased oxygen utilization and stable pH.
- Cholangiocyte function was enhanced, with increased bile production rates.
- Endothelial injury markers (resistance) and apoptosis markers (caspase 3/7) were reduced in the CEPT group.
Conclusions:
- CEPT effectively mitigates warm ischemia-induced injury in liver grafts.
- The drug cocktail promotes better graft recovery and function post-transplantation.
- Targeting the anhepatic phase with CEPT may enhance donor liver utilization.
